Efficacy of high-dose alkylating chemotherapie in HER2/neu-negative breast cancer.

Translated title of the contribution: Efficacy of high-dose alkylating chemotherapie in HER2/neu-negative breast cancer.

S. Rodenhuis, M. Bontenbal, Q.G.C.M. Van Hoesel, W.M. Smit, M.A. Nooij, E.E. Voest, E. van der Wall, P.S Hupperets, H. van Tinteren, J.L. Peterse, M.J. van de Vijver, E.G. de Vries

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionEfficacy of high-dose alkylating chemotherapie in HER2/neu-negative breast cancer.
Original languageUndefined/Unknown
Pages (from-to)588-596
Number of pages9
JournalAnnals of Oncology
Volume17
Issue number4
Publication statusPublished - 2006

Cite this